These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 21911446)

  • 1. Trimethoprim-sulfamethoxazole induced hyperkalaemia in elderly patients receiving spironolactone: nested case-control study.
    Antoniou T; Gomes T; Mamdani MM; Yao Z; Hellings C; Garg AX; Weir MA; Juurlink DN
    BMJ; 2011 Sep; 343():d5228. PubMed ID: 21911446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trimethoprim-sulfamethoxazole and risk of sudden death among patients taking spironolactone.
    Antoniou T; Hollands S; Macdonald EM; Gomes T; Mamdani MM; Juurlink DN;
    CMAJ; 2015 Mar; 187(4):E138-E143. PubMed ID: 25646289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trimethoprim use for urinary tract infection and risk of adverse outcomes in older patients: cohort study.
    Crellin E; Mansfield KE; Leyrat C; Nitsch D; Douglas IJ; Root A; Williamson E; Smeeth L; Tomlinson LA
    BMJ; 2018 Feb; 360():k341. PubMed ID: 29438980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Co-trimoxazole and sudden death in patients receiving inhibitors of renin-angiotensin system: population based study.
    Fralick M; Macdonald EM; Gomes T; Antoniou T; Hollands S; Mamdani MM; Juurlink DN;
    BMJ; 2014 Oct; 349():g6196. PubMed ID: 25359996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trimethoprim-sulfamethoxazole-induced hyperkalemia in patients receiving inhibitors of the renin-angiotensin system: a population-based study.
    Antoniou T; Gomes T; Juurlink DN; Loutfy MR; Glazier RH; Mamdani MM
    Arch Intern Med; 2010 Jun; 170(12):1045-9. PubMed ID: 20585070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beta-blockers, trimethoprim-sulfamethoxazole, and the risk of hyperkalemia requiring hospitalization in the elderly: a nested case-control study.
    Weir MA; Juurlink DN; Gomes T; Mamdani M; Hackam DG; Jain AK; Garg AX
    Clin J Am Soc Nephrol; 2010 Sep; 5(9):1544-51. PubMed ID: 20595693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Co-prescription of co-trimoxazole and spironolactone in elderly patients.
    Wei L; MacDonald TM; Mackenzie IS
    BMJ; 2011 Sep; 343():d5656. PubMed ID: 21911447
    [No Abstract]   [Full Text] [Related]  

  • 8. ACP Journal Club. Trimethoprim-sulfamethoxazole was linked to sudden death in older patients using spironolactone.
    Ananthakrishnan S
    Ann Intern Med; 2015 Jun; 162(12):JC13. PubMed ID: 26075778
    [No Abstract]   [Full Text] [Related]  

  • 9. Drug-drug interactions among elderly patients hospitalized for drug toxicity.
    Juurlink DN; Mamdani M; Kopp A; Laupacis A; Redelmeier DA
    JAMA; 2003 Apr; 289(13):1652-8. PubMed ID: 12672733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemorrhage during warfarin therapy associated with cotrimoxazole and other urinary tract anti-infective agents: a population-based study.
    Fischer HD; Juurlink DN; Mamdani MM; Kopp A; Laupacis A
    Arch Intern Med; 2010 Apr; 170(7):617-21. PubMed ID: 20386005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trimethoprim/sulfamethoxazole-induced phenytoin toxicity in the elderly: a population-based study.
    Antoniou T; Gomes T; Mamdani MM; Juurlink DN
    Br J Clin Pharmacol; 2011 Apr; 71(4):544-9. PubMed ID: 21395647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of concomitant prednisolone on trimethoprim-associated hyperkalaemia.
    Mohan S; Jaitly M; Pogue VA; Cheng JT
    J Antimicrob Chemother; 2009 Oct; 64(4):850-2. PubMed ID: 19656784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trimethoprim-sulfamethoxazole and the risk of a hospital encounter with hyperkalemia: a matched population-based cohort study.
    Hwang YJ; Muanda FT; McArthur E; Weir MA; Sontrop JM; Lam NN; Garg AX
    Nephrol Dial Transplant; 2023 May; 38(6):1459-1468. PubMed ID: 36208171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of spironolactone-associated hyperkalaemia following the Randomized Aldactone Evaluation Study (RALES).
    Hauben M; Reich L; Gerrits CM; Madigan D
    Drug Saf; 2007; 30(12):1143-9. PubMed ID: 18035866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thirty-day risk of digoxin toxicity among older adults co-prescribed trimethoprim-sulfamethoxazole versus amoxicillin: A population-based cohort study.
    Muanda FT; Weir MA; Ahmadi F; McArthur E; Sontrop JM; Abdullah SS; Urquhart BL; Sadeghi H; Kim RB; Garg AX
    Pharmacotherapy; 2024 Jul; 44(7):558-569. PubMed ID: 38922947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyperkalemia in hospitalized patients treated with trimethoprim-sulfamethoxazole.
    Alappan R; Perazella MA; Buller GK
    Ann Intern Med; 1996 Feb; 124(3):316-20. PubMed ID: 8554227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The efficacy and safety of amoxicillin, trimethoprim-sulfamethoxazole, and spironolactone for treatment-resistant acne vulgaris.
    Turowski CB; James WD
    Adv Dermatol; 2007; 23():155-63. PubMed ID: 18159900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kidney function and the use of nitrofurantoin to treat urinary tract infections in older women.
    Singh N; Gandhi S; McArthur E; Moist L; Jain AK; Liu AR; Sood MM; Garg AX
    CMAJ; 2015 Jun; 187(9):648-656. PubMed ID: 25918178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The safety of spironolactone treatment in patients with heart failure.
    Anton C; Cox AR; Watson RD; Ferner RE
    J Clin Pharm Ther; 2003 Aug; 28(4):285-7. PubMed ID: 12911680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluating the risk of hyperkalaemia and acute kidney injury with cotrimoxazole: a retrospective observational study.
    Rajput J; Moore LSP; Mughal N; Hughes S
    Clin Microbiol Infect; 2020 Dec; 26(12):1651-1657. PubMed ID: 32220637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.